These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 7485251

  • 41. An open study of risperidone liquid in the acute phase of schizophrenia.
    Yoshimura R, Nakamura J, Shinkai K, Goto M, Yamada Y, Kaji K, Kakihara S, Ueda N, Kohara K, Ninomiya H, Egami H, Maeda H.
    Hum Psychopharmacol; 2005 Jun; 20(4):243-8. PubMed ID: 15830401
    [Abstract] [Full Text] [Related]

  • 42. [Similarity of drug therapy between schizophrenia and their first degree relatives].
    Wang W.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):16-8, 61. PubMed ID: 1591952
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.
    Duncan E, Bollini AM, Sanfilipo M, Wieland S, Angrist B, Cooper TB, Rotrosen J.
    Schizophr Res; 2006 Jan 31; 81(2-3):323-6. PubMed ID: 16181774
    [No Abstract] [Full Text] [Related]

  • 45. Psychiatric illness in first degree relatives of Nigerian schizophrenic and surgical control patients.
    Adamson TA.
    Trop Geogr Med; 1993 Jan 31; 45(2):73-6. PubMed ID: 8511815
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Measurements of plasma homovanillic acid in schizophrenic patients.
    Davidson M, Kahn RS, Stern RG, Harvey PD, Keefe R, Knott P, Apter S, Webster L, Davis KL.
    Clin Neuropharmacol; 1992 Jan 31; 15 Suppl 1 Pt A():521A-522A. PubMed ID: 1354058
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Plasma homovanillic acid and prognosis in schizophrenia.
    Baker NJ, Kirch DG, Waldo M, Bell J, Adler LE, Hattox S, Murphy R, Freedman R.
    Biol Psychiatry; 1991 Jan 15; 29(2):192-6. PubMed ID: 1671646
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
    Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM.
    Science; 1984 Aug 31; 225(4665):954-7. PubMed ID: 6474162
    [Abstract] [Full Text] [Related]

  • 52. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M, Davis KL.
    Arch Gen Psychiatry; 1988 Jun 31; 45(6):561-3. PubMed ID: 3377642
    [Abstract] [Full Text] [Related]

  • 53. Genetic antecedents of dopamine dysfunction in schizophrenia.
    Amin F, Silverman JM, Siever LJ, Smith CJ, Knott PJ, Davis KL.
    Biol Psychiatry; 1999 May 01; 45(9):1143-50. PubMed ID: 10331106
    [Abstract] [Full Text] [Related]

  • 54. Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls.
    Sumiyoshi T, Saitoh O, Yotsutsuji T, Itoh H, Kurokawa K, Kurachi M.
    Neuropsychopharmacology; 1999 Apr 01; 20(4):365-9. PubMed ID: 10088137
    [Abstract] [Full Text] [Related]

  • 55. Measurement of plasma homovanillic acid concentrations in schizophrenic patients.
    Kaminski R, Powchick P, Warne PA, Goldstein M, McQueeney RT, Davidson M.
    Prog Neuropsychopharmacol Biol Psychiatry; 1990 Apr 01; 14(3):271-87. PubMed ID: 2193315
    [Abstract] [Full Text] [Related]

  • 56. Schizophrenia and plasma homovanillic acid in response to mental stress: methodological considerations.
    Sumiyoshi T, Kurachi M, Itoh H.
    Neuropsychopharmacology; 2000 Sep 01; 23(3):347-9. PubMed ID: 11032429
    [No Abstract] [Full Text] [Related]

  • 57. Variability of plasma homovanillic acid over 13 months in patients with schizophrenia; relationship with the clinical response and the Wisconsin card sort test.
    Zumárraga M, González-Torres MA, Arrue A, Dávila R, Dávila W, Inchausti L, Pérez-Cabeza L, Fernández-Rivas A, Bustamante S, Basterreche N, Guimón J.
    Neurochem Res; 2011 Aug 01; 36(8):1336-43. PubMed ID: 21475956
    [Abstract] [Full Text] [Related]

  • 58. Plasma homovanillic acid and other predictors of clozapine response.
    Pickar D.
    Clin Neuropharmacol; 1992 Aug 01; 15 Suppl 1 Pt A():516A-517A. PubMed ID: 1498935
    [No Abstract] [Full Text] [Related]

  • 59. GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.
    Arrúe A, Dávila R, Zumárraga M, Basterreche N, González-Torres MA, Goienetxea B, Zamalloa MI, Anguiano JB, Guimón J.
    Neurochem Res; 2010 Feb 01; 35(2):247-53. PubMed ID: 19701707
    [Abstract] [Full Text] [Related]

  • 60. Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
    Sharma R, Javaid JI, Janicak P, Comaty J, Davis JM, Faull K.
    Am J Psychiatry; 1988 Nov 01; 145(11):1480-1. PubMed ID: 3189613
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.